ArticleRheumatology (Oxford, England)2026

Prevalence and prognostic value of activated protein C resistance and anti-protein C antibodies in patients with aPLs: an APS ACTION Registry study.

Ibrahim Tohidi-Esfahani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.